Systemic oxidative stress in children and teenagers with Down syndrome
- PMID: 24004546
- DOI: 10.1016/j.lfs.2013.08.017
Systemic oxidative stress in children and teenagers with Down syndrome
Abstract
Aims: The aim of this study was to evaluate the antioxidant status and oxidative stress biomarkers in the blood of children and teenagers with Down syndrome.
Main methods: The analysis of enzymatic antioxidant defenses, such as the activities of catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), glutathione reductase (GR) and glutathione transferase (GST), non-enzymatic antioxidants, such as levels of reduced glutathione (GSH), uric acid (UA) and vitamin E, as well as oxidative damage indicators, such as protein carbonyls (PC) levels and lipoperoxidation (TBARS), of DS individuals (n=20) compared to healthy controls (n=18). Except the vitamin E was measured by HPLC, all other markers were measured spectrophotometrically.
Key findings: Antioxidant enzymes analysis showed significant increases in the SOD (47.2%), CAT (24.7%) and GR (49.6%) activities in DS subjects. No significant difference in GPx activity was detected while GST activity (61.2%) was decreased, and both responses may be consequence of the depletion of GSH (24.9%) levels. There were no significant differences in TBARS levels, while PC levels showed decreased (31.7%) levels compared to healthy controls, which may be related to the increase (16.1%) found in serum UA. Levels of vitamin E showed no significant differences between DS individuals compared to controls.
Significance: The results revealed a systemic pro-oxidant status in DS individuals, evidenced by the increased activity of some important antioxidant enzymes, together with decreased GSH levels in whole blood and elevated UA levels in plasma, probably as an antioxidant compensation related to the redox imbalance in DS individuals.
Keywords: Antioxidants; Down syndrome; Oxidative stress; Reactive oxygen species.
© 2013.
Similar articles
-
Antioxidant intervention attenuates oxidative stress in children and teenagers with Down syndrome.Res Dev Disabil. 2014 Jun;35(6):1228-36. doi: 10.1016/j.ridd.2014.03.013. Epub 2014 Mar 28. Res Dev Disabil. 2014. PMID: 24685938
-
Persistence of the benefit of an antioxidant therapy in children and teenagers with Down syndrome.Res Dev Disabil. 2015 Oct-Nov;45-46:14-20. doi: 10.1016/j.ridd.2015.07.010. Epub 2015 Jul 23. Res Dev Disabil. 2015. PMID: 26207872
-
Antioxidant therapy attenuates oxidative insult caused by benzonidazole in chronic Chagas' heart disease.Int J Cardiol. 2010 Nov 5;145(1):27-33. doi: 10.1016/j.ijcard.2009.06.033. Epub 2009 Jul 21. Int J Cardiol. 2010. PMID: 19625091
-
Oxidative stress parameters and antioxidants in patients with bipolar disorder: Results from a meta-analysis comparing patients, including stratification by polarity and euthymic status, with healthy controls.Bipolar Disord. 2021 Mar;23(2):117-129. doi: 10.1111/bdi.12980. Epub 2020 Sep 10. Bipolar Disord. 2021. PMID: 32780547 Review.
-
Antioxidants as potential therapeutics for neuropsychiatric disorders.Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 1;46:214-23. doi: 10.1016/j.pnpbp.2012.10.017. Epub 2012 Nov 2. Prog Neuropsychopharmacol Biol Psychiatry. 2013. PMID: 23123357 Free PMC article. Review.
Cited by
-
Accelerated bio-cognitive aging in Down syndrome: State of the art and possible deceleration strategies.Aging Cell. 2019 Jun;18(3):e12903. doi: 10.1111/acel.12903. Epub 2019 Feb 15. Aging Cell. 2019. PMID: 30768754 Free PMC article. Review.
-
Detection and Quantification of Free Radicals in Peroxisomal Disorders: A Comparative Study with Oxidative Stress Parameters.J Clin Diagn Res. 2015 Nov;9(11):SC17-20. doi: 10.7860/JCDR/2015/15629.6788. Epub 2015 Nov 1. J Clin Diagn Res. 2015. PMID: 26674249 Free PMC article.
-
Antioxidants in Down Syndrome: From Preclinical Studies to Clinical Trials.Antioxidants (Basel). 2020 Aug 3;9(8):692. doi: 10.3390/antiox9080692. Antioxidants (Basel). 2020. PMID: 32756318 Free PMC article. Review.
-
Peripheral Oxidation Markers in Down Syndrome Patients: The Better and the Worse.Dis Markers. 2021 Jun 28;2021:5581139. doi: 10.1155/2021/5581139. eCollection 2021. Dis Markers. 2021. PMID: 34257747 Free PMC article. Review.
-
Clinical aspects and biomarkers of Alzheimer's disease in Down syndrome.Free Radic Biol Med. 2018 Jan;114:3-9. doi: 10.1016/j.freeradbiomed.2017.08.024. Epub 2017 Sep 1. Free Radic Biol Med. 2018. PMID: 28870521 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous